Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma

Title
Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma
Authors
Keywords
IFN-β, PD-1, safe dose, traditional rule-based 3 + 3 design
Journal
Oncotarget
Volume 8, Issue 41, Pages -
Publisher
Impact Journals, LLC
Online
2017-04-13
DOI
10.18632/oncotarget.17090

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now